Western Europe remains at the forefront of evidence-based harm reduction and treatment interventions. The majority of the countries in the region have adopted a health-based strategy towards drug use (including decriminalisation of possession for personal use), and are moving towards more proportionate sentences for drug offences.
This EMCDDA paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that are established in the laws of many countries in Europe today.
To contribute to the UNGASS debates, the Graduate Institute of International and Development Studies held a public policy dialogue to help the technical, professional and diplomatic communities in Geneva to explore options for policy makers.
The aim of the course is to recall current trends and developments in European NPS markets, discuss current policies and identify barriers and problems in developing effective harm reduction responses targeting people who use drugs heavily in Europe.
This campaign is a network of families whose lives have been wrecked by the UK’s drug laws. Read these families' moving stories, learn more about the harms caused by punitive drug laws, and find out how you can get involved in the campaign.
This online course provides an understanding of hepatitis C and its prevalence. It also gives an overview of the liver and its function, and the stages and natural history of untreated hepatitis C liver disease.
In this study published in the British Journal of Psychiatry, supervised injectable heroin was found to be an effective way of treating heroin dependence refractory to standard treatment, in particular for patient populations previously considered unresponsive to treatment.
The conference is arranged by SERAF, City of Bergen, the Norwegian Directorate of Health and the Research Council of Norway in collaboration with proLAR, Bergen Clinics, Helse Bergen, SIRUS and the Norwegian Institute of Public Health.
This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.
In the UK there is increasing acceptance of the medical use of cannabis within the medical profession, but this has only been reflected marginally in government policy and a significant number of people are not authorised to receive medication which they believe will alleviate their condition.
For 20 years The Economist has led calls for a rethink on drug prohibition. This film looks at new approaches to drugs policy, from Portugal to Colorado. “Drugs: War or Store?” kicks off our new “Global Compass” series, examining novel approaches to policy problems.
The UK governments response, as presented by Lord Bates to Lady Meacher’s question as to whether cannabis could be re-scheduled, out of schedule one, which determines that it has no medicinal value, to schedule two or three was to parrot the Home Office’s usual line on cannabis being a harmful drug.
Supervised drug consumption facilities aim to reduce the acute risks of disease transmission through unhygienic injecting, prevent drug-related overdose deaths and connect high-risk drug users with drug dependence treatment and other health and social services.
To mark the International “Support Don’t Punish” Day of Action on 26 June, the All-Party Parliamentary Human Rights Group (PHRG) and the All-Party Parliamentary Group on the Abolition of the Death Penalty invite you to Human Rights, the Death Penalty and International Drug Control: Avenues for UK action.